CPTS Related Major News
-
Bayer to Acquire Conceptus (CPTS) in $1.1B Deal
-
Conceptus, Inc. (CPTS) Tops Q4 EPS by 6c; Issues FY13 Revs Outlook
-
Conceptus, Inc. (CPTS) Tops Q3 EPS by 2c; Affirms Outlook
-
Conceptus, Inc. (CPTS) Reports In-Line Q2 EPS
-
Conceptus, Inc. (CPTS) Tops Q1 EPS by 4c; Boosts FY12 Sales Guidance
-
Conceptus, Inc. (CPTS) Misses Q4 EPS by 6c; Guides FY12 Sales Below
-
Conceptus (CPTS) Cuts FY11 Sales Guidance Below the Street
-
Conceptus, Inc. (CPTS) Reports Q3 GAAP EPS Loss of $0.09
-
Conceptus, Inc. (CPTS) Tops Q2 EPS by 2c; Guides FY11 Sales; Announces FDA Approval to Remove Nick Contraindication from Essure Procedure Instructions
-
Conceptus, Inc. (CPTS) Misses Q1 Views; Reaffirms Outlook
-
Conceptus, Inc. (CPTS) Reported Q4 EPS of $2.66
-
Conceptus (CPTS) Guides Q4 Sales Below the Stret
-
Conceptus (CPTS) Reports Q3 Earnings; Updates Guidance for Q4 and FY
-
Conceptus, Inc. (CPTS) Reports Q2 Earnings; Issues Mixed Guidance
-
Conceptus (CPTS) In Free-Fall After Weak Outlook
-
Conceptus (CPTS) Posts Q1 adj.-EPS of $0.04, Beats Views; Reaffirms Outlook
-
Conceptus (CPTS) Reports In-Line Q4; Guides
-
Conceptus (CPTS) Reports Q3 EPS $0.20, Beats By 11c; Guides Q4 EPS
-
Conceptus (CPTS) Reports Q2 GAAP Loss of $0.02; Guides Q3, Narrows FY09 Outlook
-
Conceptus (CPTS) Reports Q1 Adj-Loss of $0.05
-
Conceptus (CPTS) Reports Mixed Q4 Earnings; Guides Q1, FY09
-
Conceptus (CPTS) Tops Q3 Views; Guides Q4
-
Conceptus (CPTS) Reports Q2 Loss of $0.05; Reaffirms Guidance
-
Conceptus (CPTS) Reports Q1 Loss of $0.21, Misses By 4c
-
Conceptus (CPTS) Reports In-Line Q4 Earnings; Issues Positive Guidance
-
Conceptus (CPTS) Raises Guidance
Back to CPTS Stock Lookup
